🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💥 The end of Pembro reign? Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: HARMONi-2 #WCLC24 #LCSM

Approach to Thrombotic Microangiopathy - Thrombocytopenia + hemolysis + schistocytes - Note: schistocytes may not always be present initially; repeat smear if suspicion high

Every year we see the SAME faces at major conferences. The #hemeonc community has PLENTY of talented physicians waiting for the right plattform to share their work.We urge ALL conference chairs to ensure that agendas are purposefully planned ensuring equal opportunity for all ♥️

👉👉👉Proud to share our brand new paper 📑 🚨 just out in Blood Journal ➡️ ➡️➡️ collaborative multi-disciplinary #HowITreat #BPDCN with focus on SCT #bmtsm #leusm #RareDisease 👉 .Mohamed Kharfan-Dabaja, MD, MBA .Andy Lane Naveen Pemmaraju, MD | MD Anderson Cancer Center #endcancer 🙌 doi.org/10.1182/blood.…

Hydroxyurea for Sickle Cell Anemia! Good stuff! Mechanism ⬆️HbF ⬇️WBC ⬇️RBC adherence to endothelium ⬆️RBC hydration = ⬆️HbS polymerization ⬆️Nitric oxide Clinical results ⬇️RBC transfusion ⬇️Hospitalization ⬇️Pain episodes No⬆️in secondary malignancies!

Congratulations to all the fellowship applicants who matched today! Welcome to Montefiore Hematology and Oncology Fellowship Program:)! Montefiore Health System Montefiore Einstein Department of Medicine Hem-Onc Fellows Network

👉👉👉How I Treat #BPDCN ASH Blood Journal Mohamed Kharfan-Dabaja, MD, MBA Andy Lane Naveen Pemmaraju, MD | #ASH24 #leusm || ashpublications.org/blood/article-…

Early morning flight from NYC to San Diego for #ASH24! ✈️☀️🌮 Looking forward to sharing our work from Upstate Cancer Center Upstate Medical University in #AML #AMLsm

Excited to learn about tp53 treatments with the awesome Montefiore Heme Onc Fellowship fellows and rising fellows at #ASH2024

Montefiore Heme Onc Fellowship well represented ASH #ASH24 including two of our incoming fellows!

#ASH24 Highlights #CommunityOnc: #Lymphoma 1. #POLARIX DLBCL 2. #inMIND FL 3. #TRIANGLE & #EA4151 MCL 4. #ENRICH MCL #Myeloma 5. #AQUILA 6. Quad MetaAnalysis 1L 7. IVIG w/ BispecificAbs 8. #CARTITUDE4 #ITP 9. #LUNA3 ASH #lymsm #mmsm #HemeTwitter 1/10

Excited to have our timely review on therapeutic interventions and early clinical trials in CH just out! Thank you to all the co-authors for a close collaboration and effort! ⁦British Journal of Haematology⁩, ⁦⁦Montefiore Health System⁩ ⁦EinsteinSCI⁩ onlinelibrary.wiley.com/doi/10.1111/bj…

A meta-analysis of the utility of cryotherapy for preventing peripheral neuropathy among #BreastCancer patients receiving paclitaxel and nab-paclitaxel buff.ly/4jmo1y9 This study evaluated the efficacy of cryotherapy combined with taxane infusion in preventing

Thanks for highlighting our recent paper.

When reports emerged in 2023 of T cell secondary malignancies in CAR-T treated pts, mechanism was unclear. New MSKCC report NEJM describes LV construct integration into TP53. Likely v rare event but does inform debate about using CAR-T early vs later. nejm.org/doi/full/10.10…

Venetoclax plus Daunorubicin and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia: Results of a Phase 1b Study ashpublications.org/blood/article-… #AML #leusm

🔥 Excited for our Phase 1 study Ven + 7+3 for Newly Diagnosed AML demonstrating 85% CR (86% MRD-neg) Blood Journal @ MontefioreNYC Albert Einstein College of Medicine - Official Montefiore Health System Eric J. Feldman Mendel Goldfinger Marina Konopleva Amit Verma Aditi Shastri, MD Kira Gritsman #leusm doi.org/10.1182/blood.…

BREAKING from NEJM In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is : 🔘Noninferior to full-dose (5 mg BID) for VTE recurrence 🔘Lower bleeding risk (12.1% vs. 15.6%) 🔘Safer extended anticoagulation, same protection.

Final (almost) wrap of the year at Korean BBQ with endless meat 🍖 🥩 and cheers to our first years finishing their toughest year of fellowship like a champ🥳🥳 Happy birthday to our May and June birthday fellows!!!🐥🐥

I am not here saying that our Montefiore Health System #ASCO25 dinner was necessarily the best of all- although i could based on the great mango lassis/ fabulous chief fellow menu and table arrangement choices and terrific company of present and past Monte hem/oncs! But has YOUR party